Skip Navigation

Restructuring the NIAID Clinical Trials Networks

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Town Hall Meeting
NIAID Clinical Trials Network: Non-HIV/AIDS Infectious Diseases

March 7, 2011
Bethesda Marriott, Bethesda, Maryland

Agenda

8:00 am - 8:30 am Welcome and Introduction
Anthony S. Fauci, M.D. Director, NIAID
8:30 am - 9:00 am Leadership Group for Non-HIV/AIDS Infectious Diseases
Carole Heilman, Ph.D., Director, Division of Microbiology & Infectious Diseases (DMID), NIAID
9:00 am - 9:30 am Structure of DAIDS Clinical Trials Networks
Carl W. Dieffenbach, Ph.D., Director, Division of AIDS (DAIDS), NIAID
9:30 am - 9:45 am Questions and Answers
9:45 am - 10:00 am Break
10:00 am - 12:30 pm Open Forum for Audience Feedback and Discussion: Audience Participation
Anthony S. Fauci, M.D., moderator
12:30 pm - 1:30 pm Lunch (optional discussion: “How does a leadership group function?” – Investigators who have participated in DAIDS Leadership Groups in the past will be available to share their experiences and insights. Lunch will be available to purchase at the hotel.)
1:30 pm - 2:10 pm Overview of Grant Application Process
Timelines and Roles
Marvin Kalt, Ph.D., Director, DEA, NIAID
Grant Mechanism and Award Process
Mary Kirker, Director, Grants Management
Questions and Answers
2:10 pm - 2:30 pm Break
2:30 pm - 3:30 pm Open Forum for Continued Feedback and Discussion
Hugh Auchincloss, M.D., Deputy Director, NIAID, moderator
3:30 pm Meeting Adjourned

Last Updated March 01, 2011

Last Reviewed March 01, 2011